Company news
Kane Biotech Inc. news in 2025
Kane Biotech Inc.'s news releases, calls and decks from 2025, newest first.
Kane Biotech Announces Closing of Private Placement Offering with an Insider of the Company
December 18, 2025
Kane Biotech Presents New Data at Innovations in Wound Healing Annual Meeting
December 17, 2025
Kane Biotech Receives Health Canada Approval for revyve® Antimicrobial Wound Gel Spray
December 10, 2025
Kane Biotech Announces Third Quarter 2025 Financial Results
November 28, 2025
Kane Biotech Announces New Private Placement Offering
November 27, 2025
Kane Biotech Presents revyve® Data at Diabetic Foot and Southern Region Burn Conferences
November 4, 2025
Kane Biotech Completes U.S. FDA 510(k) Submission for revyve® Antimicrobial Wound Cleanser
September 16, 2025
Kane Biotech Completes Enrollment in U.S. Case Series Studies of its revyve® Antimicrobial Wound Gel and Spray
September 10, 2025
Kane Biotech to Present revyve® Clinical Data at Symposium on Advanced Wound Care (SAWC) Fall Conference
September 4, 2025
Kane Biotech Announces Second Quarter 2025 Financial Results
August 28, 2025
Kane Biotech Showcases revyve™ Preclinical and Clinical Case Study Findings at North American Wound Care Conferences
July 30, 2025
Kane Biotech to Present at Advanced Wound Care Summit USA
July 14, 2025
Kane Biotech Announces Conversion of Demand Loan from Insider into an Unsecured Convertible Debenture and Annual General Meeting Voting Results
June 26, 2025
Kane Biotech Provides Further Corporate Update
June 18, 2025
Kane Biotech Announces First Quarter 2025 Financial Results
May 29, 2025
Kane Biotech Announces Closing of Private Placement Offering and Loan with Insiders of the Company
May 5, 2025
Kane Biotech Announces Fourth Quarter and Full Year 2024 Financial Results, Narrows Strategic Focus and Makes Leadership Change
April 28, 2025
Kane Biotech Announces New Agreement with Outside the Box Capital Inc.
April 11, 2025
Kane Biotech Secures IRB Approval to Launch Innovative DispersinB® Acne Trial
March 13, 2025
Kane Biotech Announces Canadian Distribution Agreement With Best Buy Medical for revyve™ Antimicrobial Wound Gel
March 11, 2025
Kane Biotech Announces Second and Final Closing of Private Placement Offering
February 19, 2025
Decks in 2025
- Investor Presentation (April 2025)
Investor deck · 14 slides · April 2025